NCT06601036View on ClinicalTrials.gov

Sevoflurane Sedation as an Alternative for Awake Fiberoptic Intubation in Difficult Airway Patients

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 17, 2024

Primary Completion Date

February 1, 2025

Study Completion Date

February 1, 2025

Conditions
SevofluraneSedationAwake Fiberoptic IntubationDifficult Airway
Interventions
DRUG

Sevoflurane

Patients will undergo fiberoptic intubation under sevoflurane sedation.

DRUG

2% Xylocaine (2 ml )

Patients will undergo fiberoptic intubation with bilateral Superior Laryngeal Nerve block and Recurrent laryngeal nerve block.

Trial Locations (1)

31527

RECRUITING

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT06601036 - Sevoflurane Sedation as an Alternative for Awake Fiberoptic Intubation in Difficult Airway Patients | Biotech Hunter | Biotech Hunter